$HALO Recent Headlines A Morgan Stanley buy, Alc
Post# of 72711
Posted On: 01/10/2014 9:34:53 PM
$HALO Recent Headlines
A Morgan Stanley buy, Alcoa's report and the streaker opens up 7:18 a.m. Oct. 8, 2013 - Shawn Langlois
Halozyme shares jump on Roche $10 million milestone payment 11:40 a.m. Sept. 27, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 10:48 a.m. Sept. 3, 2013 - Russ Britt
European regulators smile on small biotech Halozyme, and shares soar 5:22 p.m. June 28, 2013 - Russ Britt
Little-noticed firm makes a splash with pancreatic cancer treatment 1:25 p.m. May 16, 2013 - Russ Britt
6 gut checks before the stock market's opening bell 5:49 a.m. March 25, 2013 - Shawn Langlois
Synageva director bought shares for trust 1:41 p.m. Jan. 17, 2013 - Insider Monkey
Friday’s biggest gaining and declining stocks 3:51 p.m. Dec. 21, 2012 - Matt Andrejczak
ViroPharma gets okay to test reformulated Cinryze 12:09 p.m. Sept. 21, 2012 - MarketWatch.com
Halozyme soars 27% on Cinryze drug update 10:51 a.m. Sept. 21, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 8:40 a.m. Sept. 21, 2012 - Greg Morcroft
FDA lifts temporary hold on ViroPharma treatment 7:30 a.m. Sept. 21, 2012 - MarketWatch.com
Halozyme rebounds 12% in midday trading 10:21 a.m. Aug. 3, 2012 - Val Brickates Kennedy
Halozyme rebounds 10% in morning action 9:52 a.m. Aug. 3, 2012 - Val Brickates Kennedy
FDA seeks more data on Baxter, Halozyme drug 11:24 a.m. Aug. 2, 2012 - MarketWatch.com
Halozyme plunges 50% on FDA setback 9:47 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Halozyme plunges 50% on FDA setback 9:33 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 1:34 p.m. April 16, 2012 - MarketWatch
Baxter slides 6% on FDA setback 10:45 a.m. April 16, 2012 - Val Brickates Kennedy
Halozyme tumbles 27% on FDA setback 10:45 a.m. April 16, 2012 - Val Brickates Kennedy
Everything You Need to Know About Biotech M&A in a Single Chart 10:14 a.m. Jan. 7, 2014 - TheStreet.com
The Twitterverse's Biotech Stock Picks for 2014 8:00 a.m. Jan. 7, 2014 - TheStreet.com
22 Biotech Stock Predictions for 2014 7:58 a.m. Jan. 6, 2014 - TheStreet.com
BioPharma Catalyst And Investment Pick In Focus: Synergy Pharma 8:15 a.m. Jan. 2, 2014 - Seeking Alpha
Commit To Purchase Halozyme Therapeutics At $10, Earn 14.5% Using Options 11:08 a.m. Dec. 31, 2013 - TheStreet.com
Is There Still Room To Profit With Halozyme? 12:52 p.m. Dec. 27, 2013 - Seeking Alpha
Halozyme Therapeutics (HALO) Jumps: Stock Up 16.6% - Tale of the Tape 8:51 a.m. Dec. 19, 2013 - Zacks.com
Following Smart Money: Baker Brothers LLC Investments In 2013 And Beyond 8:01 a.m. Dec. 19, 2013 - Seeking Alpha
UPDATE: Halozyme Spikes Higher on Positive CNBC Comments 11:56 a.m. Dec. 18, 2013 - benzinga.com
Cramer's Lightning Round - Not Being Two-Faced About Facebook (12/5/13) 6:44 a.m. Dec. 6, 2013 - Seeking Alpha
Halozyme Therapeutics' CEO Presents at Piper Jaffray Healthcare Conference (Transcript) 4:38 p.m. Dec. 3, 2013 - Seeking Alpha
Halozyme Therapeutics (HALO) Reaches New Lifetime High Today 9:46 a.m. Nov. 22, 2013 - TheStreet.com
10-Q: HALOZYME THERAPEUTICS INC 4:37 p.m. Nov. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
Halozyme Therapeutics Management Discusses Q3 2013 Results - Earnings Call Transcript 12:03 p.m. Nov. 8, 2013 - Seeking Alpha
Today's Dead Cat Bounce Stock: Halozyme Therapeutics (HALO) 9:47 a.m. Nov. 8, 2013 - TheStreet.com
ViroPharma's Core Business Is Accelerating, New Opportunities Emerge 11:33 a.m. Nov. 6, 2013 - Seeking Alpha
Halo's Shares Should Continue To Climb 8:30 a.m. Nov. 6, 2013 - Seeking Alpha
Halozyme's Shares Should Continue To Climb 8:30 a.m. Nov. 6, 2013 - Seeking Alpha
ViroPharma Beats by a Penny - Analyst Blog 9:10 a.m. Nov. 1, 2013 - Zacks.com
Important Catalysts Approaching For These Biotechs 7:55 a.m. Oct. 22, 2013 - Seeking Alpha
Halozyme Therapeutics To Present At The 32nd Annual J.P. Morgan Healthcare Conference 4:15 p.m. Jan. 9, 2014 - PR Newswire
Healthcare Conference Schedules and Additional Loans - Research Report on Clovis Oncology, LifePoint, Halozyme, Infinity, and Endologix 8:00 a.m. Jan. 9, 2014 - PR Newswire
Halozyme Secures Additional $20 Million Term Loan 9:00 a.m. Jan. 6, 2014 - PR Newswire
Technical Briefing on Health Care Sector: Gilead Sciences, Halozyme Therapeutics, NPS Pharma, and InterMune 8:00 a.m. Dec. 26, 2013 - PR Newswire
Stock Price Updates, Executive Appointments, Acquisitions, Orphan Drug Designations, and Preclinical Developments - Research Report on Ariad, Halozyme, DepoMed, Omeros, and BioCryst 8:00 a.m. Dec. 23, 2013 - PR Newswire
Portfolio Expansions, Product Data, and Announcements by Healthcare Companies - Research Report on Life Technologies, OncoMed, Halozyme Therapeutics, Infinity, and PTC Therapeutics 8:00 a.m. Dec. 19, 2013 - PR Newswire
Intrexon Strengthens Leadership in Company's Rapidly Growing Health Sector 4:35 p.m. Dec. 17, 2013 - PR Newswire
Halozyme Therapeutics Announces Executive Transitions 4:30 p.m. Dec. 17, 2013 - PR Newswire
Dividends, FDA Approved Treatments, Clinical Data Presentations and Completed License Applications - Research Report on Medtronic, Auxilium, Alnylam, Infinity, and Halozyme 8:00 a.m. Dec. 11, 2013 - PR Newswire
Biotech Firms Participate in Upcoming Conferences; Sees Steady Numbers around Thanksgiving - Research Report on BioMarin, Halozyme, PDL BioPharma, Anika Therapeutics, and Exelis 8:00 a.m. Dec. 3, 2013 - PR Newswire
Baxter Submits Amended BLA to U.S. FDA for HyQvia for Primary Immunodeficiency 9:00 a.m. Dec. 2, 2013 - BusinessWire
Market Expert Opinion: Gilead Sciences, NPS Pharma, InterMune, and Halozyme Therapeutics 8:40 a.m. Dec. 2, 2013 - PR Newswire
Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 4:15 p.m. Nov. 26, 2013 - PR Newswire
FDA Approvals, Public Offerings and Stock Price Movements - Research Report on BioMarin, AEterna Zentaris, Charles River, Anika Therapeutics and Halozyme Therapeutics 8:00 a.m. Nov. 25, 2013 - PR Newswire
Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma 8:00 a.m. Nov. 13, 2013 - PR Newswire
Halozyme Reports Third Quarter 2013 Financial Results 8:02 a.m. Nov. 8, 2013 - PR Newswire
Halozyme Therapeutics To Present At The Credit Suisse Healthcare Conference 4:15 p.m. Nov. 6, 2013 - PR Newswire
Quarterly Dividends, Financial Results, and FDA Guidance - Research Report on Techne, ImmunoGen, Repros, Halozyme, and Synageva 8:00 a.m. Nov. 6, 2013 - PR Newswire
Under AAAResearchReports.com Microscope: Gilead Sciences Inc., NPS Pharma Inc., Halozyme Therapeutics Inc., and InterMune Inc. 11:14 a.m. Nov. 4, 2013 - PR Newswire
Halozyme to Host Third Quarter 2013 Financial Results Conference Call 9:00 a.m. Nov. 1, 2013 - PR Newswire
A Morgan Stanley buy, Alcoa's report and the streaker opens up 7:18 a.m. Oct. 8, 2013 - Shawn Langlois
Halozyme shares jump on Roche $10 million milestone payment 11:40 a.m. Sept. 27, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 10:48 a.m. Sept. 3, 2013 - Russ Britt
European regulators smile on small biotech Halozyme, and shares soar 5:22 p.m. June 28, 2013 - Russ Britt
Little-noticed firm makes a splash with pancreatic cancer treatment 1:25 p.m. May 16, 2013 - Russ Britt
6 gut checks before the stock market's opening bell 5:49 a.m. March 25, 2013 - Shawn Langlois
Synageva director bought shares for trust 1:41 p.m. Jan. 17, 2013 - Insider Monkey
Friday’s biggest gaining and declining stocks 3:51 p.m. Dec. 21, 2012 - Matt Andrejczak
ViroPharma gets okay to test reformulated Cinryze 12:09 p.m. Sept. 21, 2012 - MarketWatch.com
Halozyme soars 27% on Cinryze drug update 10:51 a.m. Sept. 21, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 8:40 a.m. Sept. 21, 2012 - Greg Morcroft
FDA lifts temporary hold on ViroPharma treatment 7:30 a.m. Sept. 21, 2012 - MarketWatch.com
Halozyme rebounds 12% in midday trading 10:21 a.m. Aug. 3, 2012 - Val Brickates Kennedy
Halozyme rebounds 10% in morning action 9:52 a.m. Aug. 3, 2012 - Val Brickates Kennedy
FDA seeks more data on Baxter, Halozyme drug 11:24 a.m. Aug. 2, 2012 - MarketWatch.com
Halozyme plunges 50% on FDA setback 9:47 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Halozyme plunges 50% on FDA setback 9:33 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 1:34 p.m. April 16, 2012 - MarketWatch
Baxter slides 6% on FDA setback 10:45 a.m. April 16, 2012 - Val Brickates Kennedy
Halozyme tumbles 27% on FDA setback 10:45 a.m. April 16, 2012 - Val Brickates Kennedy
Everything You Need to Know About Biotech M&A in a Single Chart 10:14 a.m. Jan. 7, 2014 - TheStreet.com
The Twitterverse's Biotech Stock Picks for 2014 8:00 a.m. Jan. 7, 2014 - TheStreet.com
22 Biotech Stock Predictions for 2014 7:58 a.m. Jan. 6, 2014 - TheStreet.com
BioPharma Catalyst And Investment Pick In Focus: Synergy Pharma 8:15 a.m. Jan. 2, 2014 - Seeking Alpha
Commit To Purchase Halozyme Therapeutics At $10, Earn 14.5% Using Options 11:08 a.m. Dec. 31, 2013 - TheStreet.com
Is There Still Room To Profit With Halozyme? 12:52 p.m. Dec. 27, 2013 - Seeking Alpha
Halozyme Therapeutics (HALO) Jumps: Stock Up 16.6% - Tale of the Tape 8:51 a.m. Dec. 19, 2013 - Zacks.com
Following Smart Money: Baker Brothers LLC Investments In 2013 And Beyond 8:01 a.m. Dec. 19, 2013 - Seeking Alpha
UPDATE: Halozyme Spikes Higher on Positive CNBC Comments 11:56 a.m. Dec. 18, 2013 - benzinga.com
Cramer's Lightning Round - Not Being Two-Faced About Facebook (12/5/13) 6:44 a.m. Dec. 6, 2013 - Seeking Alpha
Halozyme Therapeutics' CEO Presents at Piper Jaffray Healthcare Conference (Transcript) 4:38 p.m. Dec. 3, 2013 - Seeking Alpha
Halozyme Therapeutics (HALO) Reaches New Lifetime High Today 9:46 a.m. Nov. 22, 2013 - TheStreet.com
10-Q: HALOZYME THERAPEUTICS INC 4:37 p.m. Nov. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
Halozyme Therapeutics Management Discusses Q3 2013 Results - Earnings Call Transcript 12:03 p.m. Nov. 8, 2013 - Seeking Alpha
Today's Dead Cat Bounce Stock: Halozyme Therapeutics (HALO) 9:47 a.m. Nov. 8, 2013 - TheStreet.com
ViroPharma's Core Business Is Accelerating, New Opportunities Emerge 11:33 a.m. Nov. 6, 2013 - Seeking Alpha
Halo's Shares Should Continue To Climb 8:30 a.m. Nov. 6, 2013 - Seeking Alpha
Halozyme's Shares Should Continue To Climb 8:30 a.m. Nov. 6, 2013 - Seeking Alpha
ViroPharma Beats by a Penny - Analyst Blog 9:10 a.m. Nov. 1, 2013 - Zacks.com
Important Catalysts Approaching For These Biotechs 7:55 a.m. Oct. 22, 2013 - Seeking Alpha
Halozyme Therapeutics To Present At The 32nd Annual J.P. Morgan Healthcare Conference 4:15 p.m. Jan. 9, 2014 - PR Newswire
Healthcare Conference Schedules and Additional Loans - Research Report on Clovis Oncology, LifePoint, Halozyme, Infinity, and Endologix 8:00 a.m. Jan. 9, 2014 - PR Newswire
Halozyme Secures Additional $20 Million Term Loan 9:00 a.m. Jan. 6, 2014 - PR Newswire
Technical Briefing on Health Care Sector: Gilead Sciences, Halozyme Therapeutics, NPS Pharma, and InterMune 8:00 a.m. Dec. 26, 2013 - PR Newswire
Stock Price Updates, Executive Appointments, Acquisitions, Orphan Drug Designations, and Preclinical Developments - Research Report on Ariad, Halozyme, DepoMed, Omeros, and BioCryst 8:00 a.m. Dec. 23, 2013 - PR Newswire
Portfolio Expansions, Product Data, and Announcements by Healthcare Companies - Research Report on Life Technologies, OncoMed, Halozyme Therapeutics, Infinity, and PTC Therapeutics 8:00 a.m. Dec. 19, 2013 - PR Newswire
Intrexon Strengthens Leadership in Company's Rapidly Growing Health Sector 4:35 p.m. Dec. 17, 2013 - PR Newswire
Halozyme Therapeutics Announces Executive Transitions 4:30 p.m. Dec. 17, 2013 - PR Newswire
Dividends, FDA Approved Treatments, Clinical Data Presentations and Completed License Applications - Research Report on Medtronic, Auxilium, Alnylam, Infinity, and Halozyme 8:00 a.m. Dec. 11, 2013 - PR Newswire
Biotech Firms Participate in Upcoming Conferences; Sees Steady Numbers around Thanksgiving - Research Report on BioMarin, Halozyme, PDL BioPharma, Anika Therapeutics, and Exelis 8:00 a.m. Dec. 3, 2013 - PR Newswire
Baxter Submits Amended BLA to U.S. FDA for HyQvia for Primary Immunodeficiency 9:00 a.m. Dec. 2, 2013 - BusinessWire
Market Expert Opinion: Gilead Sciences, NPS Pharma, InterMune, and Halozyme Therapeutics 8:40 a.m. Dec. 2, 2013 - PR Newswire
Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 4:15 p.m. Nov. 26, 2013 - PR Newswire
FDA Approvals, Public Offerings and Stock Price Movements - Research Report on BioMarin, AEterna Zentaris, Charles River, Anika Therapeutics and Halozyme Therapeutics 8:00 a.m. Nov. 25, 2013 - PR Newswire
Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma 8:00 a.m. Nov. 13, 2013 - PR Newswire
Halozyme Reports Third Quarter 2013 Financial Results 8:02 a.m. Nov. 8, 2013 - PR Newswire
Halozyme Therapeutics To Present At The Credit Suisse Healthcare Conference 4:15 p.m. Nov. 6, 2013 - PR Newswire
Quarterly Dividends, Financial Results, and FDA Guidance - Research Report on Techne, ImmunoGen, Repros, Halozyme, and Synageva 8:00 a.m. Nov. 6, 2013 - PR Newswire
Under AAAResearchReports.com Microscope: Gilead Sciences Inc., NPS Pharma Inc., Halozyme Therapeutics Inc., and InterMune Inc. 11:14 a.m. Nov. 4, 2013 - PR Newswire
Halozyme to Host Third Quarter 2013 Financial Results Conference Call 9:00 a.m. Nov. 1, 2013 - PR Newswire
(0)
(0)Scroll down for more posts ▼